Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

The value of 99mTc-DTPA orbital SPECT in the drug treatment of thyroid associated ophthalmopathy

Yi Lu, Li Feng, Jin Jianhua and Jian-zhong Liu
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 309;
Yi Lu
1Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Feng
1Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Jianhua
1Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian-zhong Liu
1Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

309

Objectives To investigate the efficacy of 99mTc-DTPA orbital SPECT (TOS)in directing the treatment of thyroid associated ophthalmopathy(TAO) with periocular injection of Octreotide(OT) or Triamcinolone Acetonidc(TA).

Methods Of 50 patients with active TAO,clinical activity scores(CAS)≥3 and positive TOS,were divided into two groups treated with OT Group (OG,20 cases) or TA Group (TG,50 cases),respectively.And 12 normal volunteers were enrolled as the control(CG).CAS score,TOS and uptake ratio(UR) were detected before and after the treatment.Exophthahnometry measurements,intraocular pressure and TAO related ocular signs,including von-Graeve's sign(Gs),Dalrymple's sign(Ds) and Eniroth's sign(Es) were recorded during the treatment.The incidence of adverse reactions was also evaluated.

Results Before treatment,the patients UR levels were significantly higher than CG (F=22.517, <0.001) and no difference was found between OG and TG (P>0.05). After treatment,the UR 1evels in patients were decreased significantly (tOG=5.3l, <0.01; tTG=4.34, <0.01), and approximate to the normal (>0.05). Accordingly,the patients CAS were obviously declined after treatment (tOG=4.21, <0.01; tTG=3.89, <0.01). In addition,exophthalmia was obviously alleviated after treatment (OG:3.48mm; TG:2.61mm). As to the TAO related ocular signs,only the occurrence of Es showed a substantial decline in OG (χ2=11.958, <0.01). While,all signs frequency,including Gs,Ds and Es were significantly declined in TG (χ2=32.19,41.36 and 26.27, <0.01). The intraocular pressure showed no obvious change in both treated groups. But higher frequency of adverse reactions were found in TG compared with OG (χ2=5.396, <0.05).

Conclusions The TOS plays a critical role in evaluating the clinical activity of TAO.The patients with positive TOS show better therapeutic efficacy of OT or TA.Both drugs decrease the exophthalmia degree without elevating the intraocular pressure.Compared with OT,TA could more efficiently invert the ocular signs,but with higher frequency of adverse reactions

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The value of 99mTc-DTPA orbital SPECT in the drug treatment of thyroid associated ophthalmopathy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The value of 99mTc-DTPA orbital SPECT in the drug treatment of thyroid associated ophthalmopathy
Yi Lu, Li Feng, Jin Jianhua, Jian-zhong Liu
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 309;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The value of 99mTc-DTPA orbital SPECT in the drug treatment of thyroid associated ophthalmopathy
Yi Lu, Li Feng, Jin Jianhua, Jian-zhong Liu
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 309;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Exploring variations and utility of FDG- and NaF PET/CT in rheumatoid arthritis and osteoarthritis
  • Application of Lung perfusion only scan combined with SPECT/CT for the post-treatment evaluation of massive and sub-massive pulmonary embolism in the age of covid-19 pandemic: case presentation and literature review
  • Can FDG PET/CT imaging have a role in clinical cases of Dermatomyositis?
Show more General Clinical Specialties

Endo II: Management of Thyroid Cancer

  • Does elevated TSH in hypothyroid state elevate ovarian FDG uptake?
  • Characterization of salivary gland side effects up to 7 days after 131I therapy: Updated report of the Thyroid Cancer Survivors’ Association, Inc. (ThyCa) national survey
  • Clinical characteristics related to increased lung uptake on I-131 post-therapeutic scans in thyroid cancer
Show more Endo II: Management of Thyroid Cancer

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire